Search NASA⌕ Search

Engineering topics

Chang, Albert

Publications and source records attributed to Chang, Albert.

Improved retrievals of carbon dioxide from Orbiting Carbon Observatory-2 with the version 8 ACOS algorithm

Since September 2014, NASA's Orbiting Carbon Observatory-2 (OCO-2) satellite has been taking measurements of reflected solar spectra and using them to infer atmospheric carbon dioxide levels. This work provides details of the OCO-2 retrieval algorithm, versions 7 and 8, used to derive the column-averaged dry air mole fraction of atmospheric CO 2 ( X CO 2 ) for the roughly 100 000 cloud-free measurements recorded by OCO-2 each day. The algorithm is based on the Atmospheric Carbon Observations from Space (ACOS) algorithm which has been applied to observations from the Greenhouse Gases Observing SATellite (GOSAT) since 2009, with modifications necessary for OCO-2. Because high accuracy,better than 0.25 %, is required in order to accurately infer carbon sources and sinks from X CO 2 , significant errors and regional-scale biases in the measurements must be minimized. We discuss efforts to filter out poor-quality measurements, and correct the remaining good-quality measurements to minimize regional-scale biases. Updates to the radiance calibration and retrieval forward model in version 8 have improved many aspects of the retrieved data products. The version 8 data appear to have reduced regional-scale biases overall, and demonstrate a clear improvement over the version 7 data. In particular, error variance with respect to TCCON was reduced by 20 % over land and 40 % over ocean between versions 7 and 8, and nadir and glint observations over land are now more consistent. While this paper documents the significant improvements in the ACOS algorithm, it will continue to evolve and improve as the CO 2 data record continues to expand.

54 ENVIRONMENTAL SCIENCES↗

Predictors of Radiation Therapy–Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529

Purpose: NRG Oncology RTOG 0529 assessed the feasibility of dose-painted intensity modulated radiation therapy (DP-IMRT) to reduce the acute morbidity of chemoradiation with 5-fluorouracil (5FU) and mitomycin-C (MMC) for T2-4N0-3M0 anal cancer. This secondary analysis was performed to identify patient and treatment factors associated with acute and late gastrointestinal (GI) adverse events (AEs). Methods and Materials: NRG Oncology RTOG 0529 treatment plans were reviewed to extract dose-volume data for tightly contoured small bowel, loosely contoured anterior pelvic contents (APC), and uninvolved colon outside the target volume (UC). Univariate logistic regression was performed to evaluate association between volumes of each structure receiving doses ≥5 to 60 Gy (V5-V60) in 5-Gy increments between patients with and without grade ≥2 acute and late GI AEs, and grade ≥3 acute GI AEs. Additional patient and treatment factors were evaluated in multivariate logistic regression (acute AEs) or Cox proportional hazards models (late AEs). Results: Among 52 evaluable patients, grade ≥2 acute, grade ≥2 late, and grade ≥3 acute GI AEs were observed in 35, 17, and 10 patients, respectively. Trends (P<.05) toward statistically significant associations were observed between grade ≥2 acute GI AEs and small bowel dose (V20-V40), grade ≥2 late GI AEs and APC dose (V60), grade ≥3 acute GI AEs and APC dose (V5-V25), increasing age, tumor size >4 cm, and worse Zubrod performance status. Small bowel volumes of 186.0 cc, 155.0 cc, 41.0 cc, and 30.4 cc receiving doses greater than 25, 30, 35, and 40 Gy, respectively, correlated with increased risk of acute grade ≥2 GI AEs. Conclusions: Acute and late GI AEs from 5FU/MMC chemoradiation using DP-IMRT correlate with radiation dose to the small bowel and APC. Such associations will be incorporated in the dose-volume normal tissue constraint design for future NRG oncology anal cancer studies.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Radiotherapy for Epidermoid Carcinoma of the Anus: Thirty Years' Experience

Purpose: To evaluate the factors associated with disease control and morbidity after radiotherapy for anal carcinoma. Methods and Materials: Between 1975 and 2005, 194 patients with localized epidermoid anal carcinoma underwent radiotherapy. Treatment evolved from radiotherapy with or without surgery, to preoperative chemoradiotherapy, to definitive chemoradiotherapy (CRT). The radiotherapy techniques also evolved. Results: With a median follow-up of 61 months, 57 patients had persistence or recurrence, 9 of whom were successfully salvaged, resulting in 146 (75%) ultimately free of disease (UNED). Univariate analysis for UNED survival showed a strong association with the T and N stage (5-year UNED rate, 88.5% {+-} 3.4% for those with Stage T1-T2N0; 70.1% {+-} 4.2% for Stage T3N0; and 52.7% {+-} 6.6% for Stage III; p > .001) and mobility on palpation (5-year UNED rate, 89.2% {+-} 4.6% for those with mobile tumors vs. 59.3% {+-} 6.1% for those with tethered/fixed tumor; p > .001). No association was found with gender, age, preoperative vs. definitive CRT, or human immunodeficiency virus status. The 20 human immunodeficiency virus+ patients all received CRT. The radiotherapy factors associated with Grade 3 or greater late morbidity included anorectal morbidity with tumor dose (29% with a dose {>=}55 Gy vs. 9% otherwise), small bowel injury with technique (9% with anteroposterior-posteroanterior supine vs. 0.7% with multiple fields prone), and bone injury with femoral head dose (9% with a dose of {>=}44 Gy vs. 0.7% otherwise). Of the 194 patients, 56 had 68 additional malignancies, mainly either antedating the anal cancer or outside the radiation fields. Conclusion: Our results have confirmed that CRT is an effective approach. Patients with human immunodeficiency virus can be treated with CRT. Tumor mobility significantly predicts the outcome; the implications for management are discussed. We also discuss the treatment planning implications of the late morbidity findings. The substantial incidence of additional malignancies underscores the importance of full oncologic screening during follow-up.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Initial Processing of Infrared Spectral Data

The Atmospheric Infrared Spectrometer (AIRS) Science Processing System is a collection of computer programs, denoted product generation executives (PGEs), for processing the readings of the AIRS suite of infrared and microwave instruments orbiting the Earth aboard NASA's Aqua spacecraft. Following from level 0 (representing raw AIRS data), the PGEs and their data products are denoted by alphanumeric labels (1A, 1B, and 2) that signify the successive stages of processing. Once level-0 data have been received, the level-1A PGEs begin processing, performing such basic housekeeping tasks as ensuring that all the Level-0 data are present and ordering the data according to observation times. The level-1A PGEs then perform geolocation-refinement calculations and conversions of raw data numbers to engineering units. Finally, the level-1A data are grouped into packages, denoted granules, each of which contain the data from a six-minute observation period. The granules are forwarded, along with calibration data, to the Level-1B PGEs for processing into calibrated, geolocated radiance products. The Level-2 PGEs, which are not yet operational, are intended to process the level-1B data into temperature and humidity profiles, and other geophysical properties.

De Picciotto, Solomon↗

Tissue-Engineered Skeletal Muscle Organoids for Reversible Gene Therapy

Genetically modified murine skeletal myoblasts were tissue engineered in vitro into organ-like structures (organoids) containing only postmitotic myoribers secreting pharmacological levels of recombinant human growth hormone (rhGH). Subcutaneous organoid implantation under tension led to the rapid and stable appearance of physiological sera levels of rhGH for up to 12 weeks, whereas surgical removal led to its rapid disappearance. Reversible delivery of bioactive compounds from postmitotic cells in tissue engineered organs has several advantages over other forms of muscle gene therapy.

Vandenburgh, Herman↗

Tissue-Engineered Skeletal Muscle Organoids for Reversible Gene Therapy

Genetically modified murine skeletal myoblasts were tissue engineered in vitro into organ-like structures (organoids) containing only postmitotic myofibers secreting pharmacological levels of recombinant human growth hormone (rhGH). Subcutaneous organoid Implantation under tension led to the rapid and stable appearance of physiological sera levels of rhGH for up to 12 weeks, whereas surgical removal led to its rapid disappearance. Reversible delivery of bioactive compounds from postimtotic cells in tissue engineered organs has several advantages over other forms of muscle gene therapy.

Vandenburgh, Herman↗